Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian C. Myhr is active.

Publication


Featured researches published by Brian C. Myhr.


Mutation Research\/genetic Toxicology | 1987

Mutagenic activity of fluorides in mouse lymphoma cells.

William J. Caspary; Brian C. Myhr; Linda Bowers; Douglas B. McGregor; Colin Riach; Alison Brown

The L5178Y mouse lymphoma cell forward-mutation assay was used to test for the mutagenic activity of sodium and potassium fluoride at the thymidine kinase locus. Mutants were detected by colony formation in soft agar in the presence of trifluorothymidine. Mutagenic and toxic responses were observed in the concentration range of 300-600 micrograms/ml with both sodium and potassium fluoride. Approximately 3-fold increases in mutant frequency were observed for concentrations in the 500-700 micrograms/ml range that reduced the relative total growth to approximately 10% in the absence or presence of a rat-liver S9 activation system. A sample of 30% sodium fluoride-70% sodium bifluoride (NaHF2) induced a similar mutagenic response but was more toxic with respect to the fluoride concentration. A specificity for fluoride ions in causing mutagenesis was indicated by the fast that much higher concentrations of sodium or potassium chloride were necessary to cause toxicity and increases in the mutant frequency. The possible involvement of chromosomal changes was signaled by the predominant increase in the small colony class of mutants.


Mutation Research\/reviews in Genetic Toxicology | 1988

The mutagenic activity of selected compounds at the TK locus: Rodent vs. human cells

William J. Caspary; Robert Langenbach; Bruce W. Penman; Charles L. Crespi; Brian C. Myhr; Ann D. Mitchell

The mutagenic (TFT resistance) and toxic responses of mouse lymphoma (MOLY) L5178Y cells and human lymphoblast (HULY) TK6 cells were compared for 13 chemicals. The mutagenic activities of 8 of the 13 chemicals (62%) examined in the HULY and MOLY assays are in agreement - the results being judged positive in both assays. However, a dramatic difference is observed when the two conditions of metabolic activation are considered separately; the overall concordance of 8/13 has been achieved by combining a 13/13 (100%) agreement in the absence of S9 with a 1/6 (17%) agreement in the presence of S9. In the absence of S9, the concentration ranges, lowest significant doses, and shapes of the concentration-response curves for both toxicity and mutagenicity were similar in spite of the differences in exposure times (4 h for MOLY, 20 for HULY) and expression times (2 days for MOLY, 3 days for HULY). The general agreement observed in the absence of S9 contrasted with the differences manifested in its presence. 6 compounds which were negative in the absence of S9 were tested in both the MOLY and HULY assays in the presence of S9. Of the 6 chemicals, only 1 was positive in both MOLY and HULY under the latter condition; 4 others were positive in MOLY and negative in HULY whereas 1 was positive in HULY and negative in MOLY.


Mutation Research Letters | 1986

Mutagenicity of methylisocyanate and its reaction products to cultured mammalian cells.

William J. Caspary; Brian C. Myhr

Methylisocyanate (MIC) induced mutagenic responses in the absence of exogenous activation in the mouse lymphoma cell forward mutation assay at concentrations as low as 8-24 microM. MIC produced predominantly small mutant colonies, suggesting the possibility of clastogenic activity. The intermediate hydrolysis product, methylamine, was also mutagenic without exogenous activation but required several hundred-fold higher concentrations (ca. 3 mM). N,N-Dimethylurea, the final product in the reaction of methylisocyanate and water, was totally refractory in either the presence or absence of S9 for concentrations up to 57 mM (5 mg/ml). The ethyl ester of N-methylcarbamic acid was also tested since it was the only available analogue to the highly reactive N-methylcarbamic acid intermediate. This compound was mutagenic only in the presence of S9 at doses exceeding 5-40 microM, which suggested the possibility that the free acid, produced by enzymatic hydrolysis, is also mutagenic. The mutagenic activity of the ester resulted solely in the production of small mutant colonies.


Mutation Research Letters | 1994

The LacZ transgene in mutaTM Mouse maps to chromosome 3

Roy R. Swiger; Brian C. Myhr; James D. Tucker

Transgenic mouse models are being used with increasing frequency for mutational and toxicological studies. One such system. MutaMouse, contains a stably integrated lambda-gt10LacZ shuttle vector in the mouse genome. We describe the use of dual color fluorescence in situ hybridization (FISH) with Mus musculus whole chromosome paints and lambda DNA to map the integration site of the lambda transgene to band C on mouse chromosome 3.


Mutation Research\/genetic Toxicology | 1986

Genotoxicity of theobromine in a series of short-term assays

David Brusick; Brian C. Myhr; Sheila M. Galloway; J. Rundell; D.R. Jagannath; S. Tarka

Theobromine (3,7-dimethylxanthine) was evaluated for genotoxic activity in a series of in vitro assays. Theobromine was not mutagenic in the Ames assay up to a maximum concentration of 5000 micrograms/plate either with or without S9 activation. The compound also failed to induce significant levels of chromosome aberrations in CHO cells (with and without S9 activation) or transformation in Balb/c-3T3 cells. At the maximum tolerated concentration theobromine increased the frequency of TK-/- mutants in mouse lymphoma L5178Y cells. Increased frequencies were observed both with and without S9 activation and they were reproducible in 2 independent experiments. Statistically significant increases in SCEs were obtained in human lymphocytes and in CHO cells under nonactivation test conditions. The spectrum of results in this battery of tests indicate that theobromine treatment results in the expression of genotoxic potential in some assays and the observed activity appears qualitatively and quantitatively similar to that of caffeine, a closely related methylxanthine.


Mutation Research\/genetic Toxicology | 1986

Genotoxicity of cocoa in a series of short-term assays

David Brusick; Brian C. Myhr; Sheila M. Galloway; J. Rundell; D.R. Jagannath; S. Tarka

Cocoa powder was evaluated for genotoxic activity and found to be inactive in the Ames assay, the mouse lymphoma assay, cytogenetic assays measuring chromosome breakage and SCE, and a cell transformation assay using Balb/c-3T3 cells. Although pure theobromine has been shown to be active in some of these test procedures, the levels of this methylxanthine present in cocoa powder were insufficient to elicit responses in this battery of tests.


Mutation Research\/reviews in Genetic Toxicology | 1991

Genotoxicity under extreme culture conditions: A report from ICPEMC task group 9

David Scott; Sheila M. Galloway; Richard R. Marshall; Motoi Ishidate; David J. Brusick; John Ashby; Brian C. Myhr


Environmental and Molecular Mutagenesis | 1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty‐three coded chemicals tested at litton bionetics, inc

Brian C. Myhr; William J. Caspary


Environmental and Molecular Mutagenesis | 1988

Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Methods used and chemicals evaluated

Ann D. Mitchell; Brian C. Myhr; Colette J. Rudd; William J. Caspary; Virginia C. Dunkel


Environmental Health Perspectives | 1987

Results of In Vitro and In Vivo Genetic Toxicity Tests on Methyl Isocyanate

Michael D. Shelby; James W. Allen; William J. Caspary; Steven Haworth; James Ivett; Andrew D. Kligerman; Carol A. Luke; James M. Mason; Brian C. Myhr; Raymond R. Tice; R. Valencia; Errol Zeiger

Collaboration


Dive into the Brian C. Myhr's collaboration.

Top Co-Authors

Avatar

William J. Caspary

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew D. Kligerman

United States Environmental Protection Agency

View shared research outputs
Top Co-Authors

Avatar

Bruce W. Penman

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Carol A. Luke

Brookhaven National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Charles L. Crespi

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge